Metabolic syndrome in type 1 diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study)

Diabetes Care

Volumn 28, Issue 8, 2005, Pages 2019-2024

  Thorn, Lena M ^a,b   Forsblom, Carol ^a,b   Fagerudd, Johan ^a,b   Thomas, Merlin C ^c   Pettersson Fernholm, Kim ^a,b   Saraheimo, Markku ^a,b   Wadén, Johan ^a,b   Rönnback, Mats ^a,b   Rosengärd Bärlund, Milla ^a,b   Björkesten, Clas Göran Af ^a,b   Taskinen, Marja Riitta ^b   Groop, Per Henrik ^a,b,d  

^a BIOMEDICUM HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AMPUTATION; ARTICLE; BLOOD PRESSURE; BODY MASS; CREATININE CLEARANCE; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FINLAND; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; MULTICENTER STUDY; PREVALENCE; SEX RATIO; SMOKING; STATISTICAL ANALYSIS; STROKE;

ADULT; AGE OF ONSET; ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FINLAND; HUMANS; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; PREVALENCE;

EID: 23044481147     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.8.2019     Document Type: Article

References (34)

1. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, Taskinen M-R, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
2. Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
3. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
4. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 52-58, 2003
5. Yudkin JS: Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 22 (Suppl. 3):C25-C30, 1999
6. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
7. Groop L, Ekstrand A, Forsblom C, Widén E, Groop P-H, Teppo A-M, ErikssonJ: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:642-647, 1993
8. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen T-P, Valkonen V-P, Salonen R, Salonen JT: C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403-1410, 2004
9. Marceau P, Biron S, Hould F-S, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84: 1513-1517, 1999
10. World Health Organization: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva, World Health Organization, 1999
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
12. Chen JW, Muntner P, Hamm L, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167-174, 2004
13. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
14. Forsblom CM, ErikssonJG, Ekstrand AV, Teppo A-M, Taskinen M-R, Groop LC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 38:363-369, 1995
15. Hasslacher C, Stech W, Wahl P, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 28:6-11, 1985
16. Saraheimo M, Teppo A-M, Forsblom C, Fagerudd J, Groop P-H, FinnDiane Study Group: Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 46:1402-1407, 2003
17. Orchard TJ, Chang Y-F, Ferrell RE, Petro N, Ellis DE: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62:963-970, 2002
18. Groop P-H, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen M-R: Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes 45:974-979, 1996
19. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
20. Kidney Disease Outcome Quality Initiative: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:51-546, 2002
21. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ: Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49:626-632, 2000
22. Martin FIR, Stocks AE: Insulin sensitivity and vascular disease in insulin-dependent diabetics. BMJ 2:81-82, 1968
23. Martin FIR, Hopper JL: The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:149-153, 1987
24. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY-Z, Smithline Kinder L, Ellis D, Becker DJ: Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. Diabetes Care 26:1374-1379, 2003
25. Tan C-E, Ma S, Wai D, Chew S-K, Tai E-S: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome in Asians? Diabetes Care 27:1182-1186, 2004
26. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-141, 1979
27. Groop L: Genetics of the metabolic syndrome. Br J Nutr 83:539-548, 2000
28. Fagerudd JA, Pettersson-Fernholm KJ, Grönhagen-Riska C, Groop P-H: The impact of a family history of type 11 (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 42:519-526, 1999
29. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
30. Svensson M, Yu ZW, Eriksson JW: A small reduction in gloraerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy. Eur J Clin Invest 32:100-109, 2002
31. Deckert T, Feldt-Rasrnussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219-226, 1989
32. Cleland SJ, Petrie JR, Small M, Elliott HL, Connell JM: Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 35:507-511, 2000
33. Yki-Järvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
34. Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH: Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 18:786-796, 2001